Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate and adaptive immune cell function encompasses the coordinated activities of the body's defense mechanisms against pathogens and malignancies. The innate immune system provides the first line of defense through non-specific mechanisms such as phagocytosis, physical barriers, and the complement system (StatPearls, 2023). In contrast, the adaptive immune system involves specialized cells like B and T lymphocytes that recognize specific antigens and establish long-term immunological memory (NIH, 2022). Proper regulation of these functions is critical, as deficiencies can lead to severe infections or immunodeficiency, while overactivity or loss of self-tolerance results in autoimmune diseases and chronic inflammation (Nature Reviews Immunology, 2021). While numerous therapeutic agents, including monoclonal antibodies and small molecule inhibitors, modulate specific pathways within these systems, the term itself represents a broad physiological process rather than a single molecular target.
Not applicable as this is a broad biological process rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate and adaptive immune cell function.